Dr. Matthew Vander Heiden, MD
Dr. Matthew Vander Heiden, MD is a medical oncologist in Boston, MA and has over 20 years of experience in the medical field. He graduated from University of Chicago Pritzker School of Medicine in 2002. He is affiliated with medical facilities such as Brigham and Women's Hospital and Massachusetts General Hospital. He is accepting new patients.
Dana-Farber Cancer Institute
450 Brookline Ave Boston, MA 02215Make an Appointment
Hospital Highlight
Dr. Vander Heiden is affiliated with Massachusetts General Hospital Boston, a highly rated hospital.
At a Glance
- Area of Expertise
- Practices at Top Hospital
- Hospital Satisfaction
Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Vander Heiden's Reviews
Overall Patient Satisfaction
About Me
biography
Dr. Matthew Vander Heiden, MD is a medical oncologist in Boston, MA and has over 20 years of experience in the medical field. He graduated from University of Chicago Pritzker School of Medicine in 2002. He is affiliated with medical facilities...read moreMedical Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Brigham And Women's Hospital
Residency HospitalUniversity Of Chicago Pritzker School Of Medicine
Medical School, 2002
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkPyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis, 2012-09-07
The CAT-SIR is out of the bag: tumors prefer host rather than dietary nutrients, 2021-05-10
Identification of DHODH as a therapeutic target in small cell lung cancer, 2019-11-06
Heterogeneity of tumor-induced gene expression changes in the human metabolic network, 2013-04-21
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation, 2009-05-22
PKM2 is not required for pancreatic ductal adenocarcinoma, 2018-10-23
Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma, 2020-07-10
Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d -2-Hydroxyglutarate, 2014-11-18
Emerging roles for branched chain amino acid metabolism in cancer, 2020-02-10
Cell state-specific metabolic dependency in hematopoiesis and leukemogenesis, 2014-09-11
Pyruvate as a Pivot Point for Oncogene-Induced Senescence, 2013-06-20
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis, 2011-07-31
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia, 2011-11-20
Increased PHGDH expression promotes aberrant melanin accumulation, 2019-07-22
Patient-derived xenografts to study cancer metabolism: when does X mark the spot?, 2021-09-01
Identification of small molecule inhibitors of pyruvate kinase M2, 2009-12-11
Low glycemic diets alter lipid metabolism to influence tumor growth, 2021-10-20
Antibody-Mediated Neutralization of Perfringolysin O for Intracellular Protein Delivery, 2015-05-04
Understanding metabolic regulation and its influence on cell physiology, 2013-02-07
Pyruvate kinase M1 suppresses development and progression of prostate adenocarcinoma, 2022-07-05
The Metabolic Landscape of RAS-Driven Cancers from biology to therapy, 2021-03-24
Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer, 2016-02-04
The nutrient microenvironment affects cancer therapy, 2018-06-01
Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting, 2018-08-16
Slow TCA flux and ATP production in primary solid tumours but not metastases, 2023-02-01
Regulation of chromatin accessibility by the histone chaperone CAF-1 sustains lineage fidelity, 2022-04-29
Cancer-associated mutations in human pyruvate kinase M2 impair enzyme activity, 2019-11-16
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1, 2020-06-08
Cell Programmed Nutrient Partitioning in the Tumor Microenvironment, 2021-04-07
Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy, 2012-09-21
A PHGDH inhibitor reveals coordination of serine synthesis and 1-carbon unit fate, 2016-04-25
Aspartate is an endogenous metabolic limitation for tumour growth, 2018-06-25
Understanding the intersections between metabolism and cancer biology, 2017-02-09
PKM1 Exerts Critical Roles in Cardiac Remodeling under Pressure Overload in the Heart, 2021-06-09
Nucleotide imbalance decouples cell growth from cell proliferation, 2022-08-04
EGLN1 Inhibition and Rerouting of a-Ketoglutarate Suffice for Remote Ischemic Protection, 2016-02-25
MFSD7C switches mitochondrial ATP synthesis to thermogenesis in response to heme, 2020-09-24
Keap1loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis, 2017-10-02
Author Correction: Cooperative nutrient accumulation sustains growth of mammalian cells, 2020-07-21
Biochemical Underpinnings of Immune Cell Metabolic Phenotypes, 2017-05-16
Activation of a metabolic gene regulatory network downstream of mTOR complex 1, 2010-07-30
PKM2 is not required for colon cancer initiated by APC loss, 2017-11-30
A Broad-Spectrum Integrative Design for Cancer Prevention and Therapy, 2016-03-12
Lack of evidence for PKM2 protein kinase activity, 2015-08-20
Cooperative nutrient accumulation sustains growth of mammalian cells, 2015-12-01
Metabolomics in Cancer Research and Emerging Applications in Clinical Oncology, 2021-05-13
A roadmap for interpreting13C metabolite labeling patterns from cells, 2015-02-28
Pyruvate kinase: function, regulation and role in cancer, 2015-08-13
Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis, 2012-06-01
ADERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect, 2014-04-03
Increased demand for NAD+ relative to ATP drives aerobic glycolysis, 2020-12-30
Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance, 2019-09-04
Height, obesity, and the risk ofTMPRSS2:ERG-defined prostate cancer, 2017-11-22
Dysregulated metabolism contributes to oncogenesis, 2015-10-08
FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS, 2021-04-01
Publisher Correction: A metastasis map of human cancer cell lines, 2021-11-03
Deficiency of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis, 2020-11-26
Metabolic requirements for cancer cell proliferation, 2016-08-18
Famine versus feast: understanding the metabolism of tumorsin vivo, 2015-01-29
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells, 2013-05-12
Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance, 2020-08-06
Focus on Breast Cancer
Locations
Dana-Farber Cancer Institute
Affiliated Hospitals
- Recipient of 31
hospital awardsAmerica's 250 Best Hospitals Award™ (2025, 2024)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all awardsSurgical Care Excellence Award™ (2025)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all patient feedbackHow patients felt about the care they received at this hospital.
90%Patients said they were given information about recovering at home6% higher than the national average
86%Patients would recommend the hospital to friends and family21% higher than the national average
- Recipient of 31
hospital awardsAmerica's 250 Best Hospitals Award™ (2025)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all awardsOutstanding Patient Experience Award™ (2024, 2023, 2022)
Top in the nation for overall patient experience based on nine measures related to doctor and nurse communication, hospital cleanliness and noise levels, and medication and post-discharge care instructions
View all patient feedbackHow patients felt about the care they received at this hospital.
91%Patients said they were given information about recovering at home7% higher than the national average
84%Patients said that nurses always listened to them and explained things well9% higher than the national average
Compare Providers
Providers shown based on Dr. Vander Heiden's location and specialty. Show more Oncologists.